UNSPSC 85821202: Measurement of intracranial temperature, percutaneous approach

This classification denotes the group of activities that yields a measurement intervention or procedure to measurement of intracranial temperature, percutaneous approach. This measurement intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 4A003KD

UNSPSC 85821202 Measurement of intracranial temperature, percutaneous approach is a Commodity code that bears little relevance to the recent state and local contract opportunities identified under it. The code nominally describes a specific medical device or procedure—intracranial temperature measurement via percutaneous methods—yet the recent solicitations posted under this code span telehealth platforms, nursing home operations, occupational health services, cancer screening, retinal imaging devices, EMS staffing, employee wellness programs, and opioid use disorder treatment. The mismatch between the code's technical name and the actual work being procured suggests either systematic miscoding or a taxonomy misalignment within the issuing procurement systems.

State and local governments posting under this code show no recent activity that matches the intracranial temperature measurement scope. The most recent opportunities—including Inland Empire Health Plan's virtual urgent care RFI (Oct 16, 2026), Nevada Health Authority's PACE operations RFP (Oct 8, 2026), and San Mateo County's cancer registry and retinal screening device RFPs (Oct 5 and Oct 1, 2026)—pursue comprehensive health service delivery, behavioral health operations, occupational health screening, and medical device leasing, none of which involve neurological temperature monitoring. This pattern repeats across the entire opportunity set, spanning counties in California, Georgia, Nevada, Colorado, Florida, Missouri, Texas, and beyond, with zero instances of intracranial monitoring procurement. The code shows no decision-relevant recent activity for firms pursuing state and local work in neurological measurement or neuromonitoring services.